Sandra Horning
Hematology & Oncology · Stanford, CANPI 1578607669
Payments from drug & device makers
$2,486,406in general payments, 2019–2025
Across 233 payments — averaging $10,671 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2M
- Modernatx, Inc.$447K
- Genentech USA, Inc.$135
What the payments were for
- Consulting fees$2,328,70994%
- Speaking & faculty fees$119,9495%
- Travel & lodging$31,2331%
- Food & beverage$6,5160%
General payments by program year
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 191 | $2,038,904 |
| Modernatx, Inc. | 41 | $447,368 |
| Genentech USA, Inc. | 1 | $135 |
How this compares
$2,486,406 in reported general payments places this provider in the 90th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Stanford
- Alain AlgaziSan Francisco$119.2M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Nicholas McAndrewLos Angeles$22.9M
- Aditya BardiaSanta Monica$22.1M
- Joseph TuscanoSacramento$20.4M
- Zev WainbergSanta Monica$19.3M
- Caitlin CostelloSan Diego$16.9M
- Rana McKaySan Diego$15.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.